Form 4 for XTNT Xtant Medical Holdings, Inc.
Accepted 2026-08-18 17:47:41 ET · period of report 2026-08-15 · accession 0001790461-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 17:47 | 2026-08-15 | XTNT | Browne Sean E | Pres, CEO, Dir | A - Grant | $0.00 | +550.0K | 3.13M | +21% | $0 | |
| 2026-08-18 17:47 | 2026-08-15 | XTNT | Browne Sean E | Pres, CEO, Dir | F - Tax | $0.31 | -10.6K | 3.11M | -0.3% | -$3,288 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-15 | A | A | 550,000 | $0.00 | 3,125,274 | D | — | — | (F1) These shares will vest with respect to 137,500 shares on each of August 15, 2027, August 15, 2028, August 15, 2029 and August 15, 2030 pursuant to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock. (F2) Includes an aggregate of 1,720,123 shares issuable upon vesting and settlement of restricted stock unit awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates. |
| 2 | Common | Common Stock | 2026-08-15 | F | D | 10,605 | $0.31 | 3,114,669 | D | — | — | (F3) These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards. (F3) These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards. (F2) Includes an aggregate of 1,720,123 shares issuable upon vesting and settlement of restricted stock unit awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates. |